Skip to main content
ADIM logo

ADIM — Investor Relations & Filings

Ticker · 4142 ISIN · TW0004142005 LEI · 549300M5TV8YGVXU1827 TW Manufacturing
Open in API
Filings indexed 1,804 across all filing types
Latest filing 2017-05-12 Regulatory Filings
Country TW Taiwan
Listing TW 4142

About ADIM

http://www.adimmune.com.tw/

ADIMMUNE CORPORATION, established in 1965, specializes in the research, development, and large-scale manufacturing of human vaccines and biologics. The company is a primary supplier of seasonal influenza and tetanus vaccines, maintaining production facilities that adhere to PIC/S GMP, US FDA, and EU standards. Its operations encompass the full product lifecycle, from initial R&D to commercial distribution. In addition to its proprietary vaccine portfolio, the company provides Contract Development and Manufacturing Organization (CDMO) services, supporting collaborative development and global supply chains. Recognized for its technical expertise in viral and bacterial vaccine production, the organization focuses on delivering high-quality immunization solutions to international markets while leveraging its history as a pioneering vaccine laboratory.

Recent filings

Filing Released Lang Actions
106年第1季大陸投資
Regulatory Filings Classification · 95% confidence The document is a tabular disclosure of investment information related to investments in mainland China by a Taiwanese listed company, including capital amounts, investment methods, and investment income recognized. It includes notes explaining the investment methods and accounting bases for investment income recognition. The document is short (1278 characters) and does not contain comprehensive financial statements or detailed financial analysis. It appears to be a regulatory disclosure related to investment activities rather than a full financial report or earnings release. There is no indication that this is an announcement of a report publication or a certification. The content fits best under Regulatory Filings (RNS) as a general regulatory disclosure that does not fit other specific categories such as Annual Report, Interim Report, or Capital/Financing Update.
2017-05-12 Chinese
公告本公司董事會決議庫藏股轉讓員工並訂定認股基準日
Transaction in Own Shares Classification · 95% confidence The document is a short announcement (682 characters) from a company (國光生物科技股份有限公司) regarding a board resolution to transfer treasury shares to employees and setting a record date for employee stock subscription. It mentions the number of shares, average price, and the subscription date. There is no detailed financial data, no full report, and the document is clearly an announcement of a capital change related to treasury shares and employee stock transfer. This fits the category of 'Transaction in Own Shares' (POS) rather than a full financial report or other categories. The document is not a report publication announcement or regulatory filing fallback, but a specific capital transaction announcement.
2017-05-11 Chinese
106年4月營業收入
Regulatory Filings Classification · 90% confidence The document is a revenue summary report for a company named 國光生 for the period 民國106年04月 (April 2017). It provides monthly and cumulative net operating revenue figures with percentage changes and explanations for revenue changes. The document is short (782 characters) and contains summarized financial data but does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure of revenue figures rather than a full financial report or earnings release. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2017-05-10 Chinese
106年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, providing information about loan balances and endorsement guarantees for the current and previous months. It contains no detailed financial statements, management discussion, or regulatory certifications. The content is concise and factual, typical of a regulatory announcement or compliance disclosure rather than a full report or presentation. Given the short length (616 characters) and the nature of the data, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2017-05-10 Chinese
106年04月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, supervisors, and executives, with specific numbers of shares held, pledged shares, and related percentages. It is a disclosure of insider shareholdings and changes, typical of a Director's Dealing or insider shareholding notification. The document is relatively short (3436 characters) and does not contain financial statements, earnings data, or management discussion. It does not announce voting results, dividends, or capital changes. The content is focused on insider shareholdings and pledges, which aligns with the category of Director's Dealing (DIRS).
2017-05-09 Chinese
106年04月內部人持股異動(事後)
Major Shareholding Notification Classification · 95% confidence The document contains detailed tables listing shareholdings of insiders, including directors, supervisors, and senior management, with specific data on shares held, increases, decreases, and trust shares. The content focuses on insider shareholding disclosures rather than financial results, management changes, or meeting materials. There is no indication of financial statements, earnings data, or meeting results. The document is a regulatory disclosure of insider shareholdings, which aligns with the category of Major Shareholding Notification (MRQ). The document length is substantial and contains actual data, not just an announcement or certification, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA). Therefore, the best classification is Major Shareholding Notification (MRQ).
2017-05-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.